Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:467-477

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ravandi, A.
Right arrow Articles by Shaikh, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ravandi, A.
Right arrow Articles by Shaikh, N. A.
Related Collections
Right arrow Pathophysiology
Right arrow Lipid and lipoprotein metabolism
Right arrow Oxidant stress
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:467.)
© 2000 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Glucosylated Glycerophosphoethanolamines are the Major LDL Glycation Products and Increase LDL Susceptibility to Oxidation

Evidence of Their Presence in Atherosclerotic Lesions

Amir Ravandi; Arnis Kuksis; Nisar A. Shaikh

From the Department of Laboratory Medicine and Pathobiology (A.R., N.A.S.), and Banting and Best Department of Medical Research (A.R., A.K.), University of Toronto; and Spectral Diagnostics Inc (N.A.S.), Toronto, Canada.

Correspondence to Dr Arnis Kuksis, Banting and Best Department of Medical Research, University of Toronto, 112 College St, Toronto, Ontario M5G 1L6, Canada. E-mail arnis.kuksis{at}utoronto.ca

Abstract—Glycation of both protein and lipid components is believed to be involved in LDL oxidation. However, the relative importance of lipid and protein glycation in the oxidation process has not been established, and products of lipid glycation have not been isolated. Using glucosylated phosphatidylethanolamine (Glc PtdEtn) prepared synthetically, we have identified glycated diacyl and alkenylacyl species among the ethanolamine phospholipids in LDL. Accumulation of these glycation products in LDL incubated with glucose showed a time- and glucose concentration–dependent increase. LDL specifically enriched with Glc PtdEtn (25 nmol/mg protein) showed increased susceptibility to lipid oxidation when dialyzed against a 5-µmol/L Cu2+ solution. The presence of this glucosylated lipid resulted in a 5-fold increase in production of phospholipid-bound hydroperoxides and 4-fold increase in phospholipid-bound aldehydes. Inclusion of glucosylated phosphatidylethanolamine in the surface lipid monolayer of the LDL resulted in rapid loss of polyunsaturated cholesteryl esters from the interior of the particle during oxidation. Glycated ethanolamine phospholipids were also isolated and identified from atherosclerotic plaques collected from both diabetic and nondiabetic subjects. The present findings provide direct evidence for the previously proposed causative effect of lipid glycation on LDL oxidation.


Key Words: low-density lipoproteins • peroxidation, lipid • glycation, phospholipid • diabetes • atheroma




This article has been cited by other articles:


Home page
IOVSHome page
M. Wu, Y. Chen, K. Wilson, A. Chirindel, M. A. Ihnat, Y. Yu, M. E. Boulton, L. I. Szweda, J.-X. Ma, and T. J. Lyons
Intraretinal Leakage and Oxidation of LDL in Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2679 - 2685.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
O. Higuchi, K. Nakagawa, T. Tsuzuki, T. Suzuki, S. Oikawa, and T. Miyazawa
Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5'-phosphate as the inhibitor
J. Lipid Res., May 1, 2006; 47(5): 964 - 974.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Nakagawa, J.-H. Oak, O. Higuchi, T. Tsuzuki, S. Oikawa, H. Otani, M. Mune, H. Cai, and T. Miyazawa
Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes
J. Lipid Res., November 1, 2005; 46(11): 2514 - 2524.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J.-H. Oak, K. Nakagawa, and T. Miyazawa
UV analysis of Amadori-glycated phosphatidylethanolamine in foods and biological samples
J. Lipid Res., March 1, 2002; 43(3): 523 - 529.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. J. Jarvisalo, A. Putto-Laurila, L. Jartti, T. Lehtimaki, T. Solakivi, T. Ronnemaa, and O. T. Raitakari
Carotid Artery Intima-Media Thickness in Children With Type 1 Diabetes
Diabetes, February 1, 2002; 51(2): 493 - 498.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
M. Mazzali, T. Kipari, V. Ophascharoensuk, J.A. Wesson, R. Johnson, and J. Hughes
Osteopontin--a molecule for all seasons
QJM, January 1, 2002; 95(1): 3 - 13.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
U. Jurt, T. Gori, A. Ravandi, S. Babaei, P. Zeman, and J. D. Parker
Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 854 - 859.
[Abstract] [Full Text] [PDF]